| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |